Page last updated: 2024-09-03

ezogabine and Bipolar Disorder

ezogabine has been researched along with Bipolar Disorder in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nielsen, AN; Redrobe, JP1
Dencker, D; Husum, H1
Hansen, HH; Kristensen, LV; Sandager-Nielsen, K1
Amann, B; Grunze, H; Stampfer, R; Sterr, A; Vieta, E; Walden, J1
Dencker, D; Dias, R; Husum, H; Pedersen, ML1

Trials

1 trial(s) available for ezogabine and Bipolar Disorder

ArticleYear
An exploratory open trial on safety and efficacy of the anticonvulsant retigabine in acute manic patients.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:5

    Topics: Acute Disease; Adult; Anticonvulsants; Bipolar Disorder; Carbamates; Female; Humans; Male; Middle Aged; Patient Dropouts; Phenylenediamines; Pilot Projects; Psychiatric Status Rating Scales; Treatment Outcome

2006

Other Studies

4 other study(ies) available for ezogabine and Bipolar Disorder

ArticleYear
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
    Behavioural brain research, 2009, Mar-17, Volume: 198, Issue:2

    Topics: Amphetamine; Animals; Anticonvulsants; Antimanic Agents; Benzamides; Bipolar Disorder; Carbamates; Central Nervous System Stimulants; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Indoles; Injections, Intraperitoneal; KCNQ Potassium Channels; Lamotrigine; Lithium Compounds; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenylenediamines; Pyridines; Triazines

2009
Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
    Behavioural brain research, 2010, Feb-11, Volume: 207, Issue:1

    Topics: Amphetamine; Analysis of Variance; Animals; Anticonvulsants; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Carbamates; Disease Models, Animal; Dose-Response Relationship, Drug; Food Preferences; Lithium Chloride; Male; Mice; Motor Activity; Phenylenediamines; Saccharin; Treatment Outcome

2010
K(v) 7 (KCNQ) channel openers normalize central 2-deoxyglucose uptake in a mouse model of mania and increase prefrontal cortical and hippocampal serine-9 phosphorylation levels of GSK3β.
    Journal of neurochemistry, 2012, Volume: 121, Issue:3

    Topics: Animals; Antimanic Agents; Autoradiography; Benzamides; Bipolar Disorder; Carbamates; Central Nervous System Stimulants; Chlordiazepoxide; Deoxyglucose; Dextroamphetamine; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypnotics and Sedatives; KCNQ Potassium Channels; Male; Mice; Mice, Inbred C57BL; Phenylenediamines; Phosphorylation; Prefrontal Cortex; Pyridines; Serine

2012
Effect of the new antiepileptic drug retigabine in a rodent model of mania.
    Epilepsy & behavior : E&B, 2008, Volume: 12, Issue:1

    Topics: Amphetamine; Animals; Anticonvulsants; Behavior, Animal; Bipolar Disorder; Carbamates; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Lamotrigine; Lithium Chloride; Male; Motor Activity; Phenylenediamines; Rats; Rats, Wistar; Triazines

2008